Evidence map›Paper›PMID 30626644›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Ribosomal protein RPL26 is the principal target of UFMylation.

Christopher P Walczak, Dara E Leto, Lichao Zhang, Celeste Riepe, Ryan Y Muller, Paul A DaRosa, Nicholas T Ingolia, Joshua E Elias, Ron R Kopito

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 205 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. The mechanistic basis and cellular functions of UFMylation.Nature reviews. Molecular cell biology · 2026
    Review
  9. Evaluating evidence for UFMylation client diversity.Nature reviews. Molecular cell biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. UFMylation of Pyruvate Dehydrogenase Regulates Mitochondrial Metabolism.bioRxiv : the preprint server for biology · 2026
    Article
  18. Article
  19. Ribosome-associated quality control and related mechanisms.Nature structural & molecular biology · 2026
    Review
  20. Review

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Christopher P WalczakDepartment of Biology, Stanford University, Stanford, CA 94305.
Dara E LetoDepartment of Biology, Stanford University, Stanford, CA 94305.
Lichao ZhangDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305.
Celeste RiepeDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
Ryan Y MullerDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
Paul A DaRosaDepartment of Biology, Stanford University, Stanford, CA 94305.
Nicholas T IngoliaDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
Joshua E EliasDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305.
Ron R KopitoDepartment of Biology, Stanford University, Stanford, CA 94305; kopito@stanford.edu.
Stanford University · USUniversity of California, Berkeley · US

Funding

The Ubiquitin Proteasome System in Quality ControlR01GM074874 · NIGMS · STANFORD UNIVERSITY · PI KOPITO, RON R · 2006 to 2022
$8.0M
Molecular Basis and Cellular Roles of Translational RegulationDP2CA195768 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI INGOLIA, NICHOLAS T · 2014 to 2014
$2.4M
Pacific Biosciences PacBio RS Single Molecule Real Time SequencerS10OD018174 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ROKHSAR, DANIEL SOLEYMAN · 2014 to 2014
$600k
Elucidating the architecture of native multiprotein complexes involved in ER-associated degradationF32GM113378 · NIGMS · STANFORD UNIVERSITY · PI WALCZAK, CHRISTOPHER PAUL · 2015 to 2017
$168k
Genetic interaction (GI) analysis of the mammalian ERAD systemF32GM113370 · NIGMS · STANFORD UNIVERSITY · PI LETO, DARA · 2015 to 2015
$58k
NCI NIH HHS DP2 CA195768NIGMS NIH HHS F32 GM113370NIGMS NIH HHS F32 GM113378NIGMS NIH HHS R01 GM074874NIH HHS S10 OD018174
6 · The paper itself

Abstract

Ubiquitin fold modifier 1 (UFM1) is a small, metazoan-specific, ubiquitin-like protein modifier that is essential for embryonic development. Although loss-of-function mutations in UFM1 conjugation are linked to endoplasmic reticulum (ER) stress, neither the biological function nor the relevant cellular targets of this protein modifier are known. Here, we show that a largely uncharacterized ribosomal protein, RPL26, is the principal target of UFM1 conjugation. RPL26 UFMylation and de-UFMylation is catalyzed by enzyme complexes tethered to the cytoplasmic surface of the ER and UFMylated RPL26 is highly enriched on ER membrane-bound ribosomes and polysomes. Biochemical analysis and structural modeling establish that UFMylated RPL26 and the UFMylation machinery are in close proximity to the SEC61 translocon, suggesting that this modification plays a direct role in cotranslational protein translocation into the ER. These data suggest that UFMylation is a ribosomal modification specialized to facilitate metazoan-specific protein biogenesis at the ER.

Indexed as

Carrier ProteinsCell LineCell Line, TumorCytoplasmEndoplasmic ReticulumEndoplasmic Reticulum StressHEK293 CellsHumansK562 CellsPolyribosomesProtein BindingProtein TransportRibosomal ProteinsRibosomesUbiquitin-Conjugating EnzymesCarrier ProteinsRibosomal ProteinsRPL26 protein, humanUbiquitin-Conjugating Enzymesendoplasmic reticulumRPL26UFM1UFMylation

Identifiers

PMID30626644
PMCPMC6347690
OpenAlexW2909869524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.